Ashley Alexander Grist
Vorstandsvorsitzender bei Vertex Pharmaceuticals (Germany) GmbH
Ursprung des Netzwerks ersten Grades von Ashley Alexander Grist
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Vertex Pharmaceuticals (France) SAS
 Vertex Pharmaceuticals (France) SAS Pharmaceuticals: MajorHealth Technology Part of Vertex Pharmaceuticals, Inc., Vertex Pharmaceuticals (France) SAS develops and manufactures pharmaceutical products. The company is based in Paris, France. The CEOs are Michele Bellandi, Jonathan Oppenheim. The French company was founded in 2011.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Vertex Pharmaceuticals (Germany) GmbH
 Vertex Pharmaceuticals (Germany) GmbH Medical DistributorsDistribution Services Part of Vertex Pharmaceuticals, Inc., Vertex Pharmaceuticals (Germany) GmbH is a company that invests in science to improve people's lives. The company is based in Munich, Germany. The company is focused on discovering, developing, and producing innovative medicines for individuals with serious diseases. The CEOs are Ashley Alexander Grist, Georg Pirmin Meyer, Yves Alexander Zinggeler. The company was founded in 2011.
2
| Subsidiary | Medical Distributors | 2 |
Vertex Pharmaceuticals (Europe) Ltd.
 Vertex Pharmaceuticals (Europe) Ltd. Medical DistributorsDistribution Services Vertex Pharmaceuticals (Europe) Ltd. operates as a pharmaceutical firm. The company was founded on March 11, 1994 and is headquartered London, the United Kingdom.
2
| Subsidiary | Medical Distributors | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Ashley Alexander Grist
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Vertex Pharmaceuticals (U.K.) Ltd.
 Vertex Pharmaceuticals (U.K.) Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2011, Vertex Pharmaceuticals (U.K.) Ltd. is a subsidiary of Vertex Pharmaceuticals, Inc. that engages in research and experimental development on natural science. The company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistik
International
| Vereinigtes Königreich | 3 |
Sektoral
| Commercial Services | 2 |
| Health Technology | 2 |
Operativ
| Chief Executive Officer | 4 |
| Director/Board Member | 4 |
| Corporate Officer/Principal | 1 |
| Chief Operating Officer | 1 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Ashley Alexander Grist
- Unternehmensverbindungen
